Antonio Giordano

56.1k total citations · 12 hit papers
874 papers, 36.6k citations indexed

About

Antonio Giordano is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antonio Giordano has authored 874 papers receiving a total of 36.6k indexed citations (citations by other indexed papers that have themselves been cited), including 414 papers in Molecular Biology, 393 papers in Oncology and 135 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antonio Giordano's work include Cancer-related Molecular Pathways (196 papers), Ubiquitin and proteasome pathways (64 papers) and Epigenetics and DNA Methylation (58 papers). Antonio Giordano is often cited by papers focused on Cancer-related Molecular Pathways (196 papers), Ubiquitin and proteasome pathways (64 papers) and Epigenetics and DNA Methylation (58 papers). Antonio Giordano collaborates with scholars based in United States, Italy and United Kingdom. Antonio Giordano's co-authors include Umberto Galderisi, Cristina Giacinti, Antonio De Luca, Giuseppina Tommonaro, Silvia Lapenna, Pier Paolo Claudio, Alfonso Baldi, Margaret M. Kasten, Luigi Bagella and Maria Laura Avantaggiati and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Antonio Giordano

852 papers receiving 36.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RB and cell cycle progression

2006 921 citations Antonio Giordano et al. profile →
Formation and Activation of a Cyclin E-cdk2 Complex During the G ₁ Phase of the Human Cell Cycle

1992 911 citations Antonio Giordano et al. profile →
Curcumin and Cancer

2019 747 citations Antonio Giordano et al. Nutrients profile →
Cell cycle kinases as therapeutic targets for cancer

2009 745 citations Antonio Giordano et al. profile →
Recruitment of p300/CBP in p53-Dependent Signal Pathways

1997 585 citations Antonio Giordano et al. profile →
Cell Cycle and Apoptosis

2000 545 citations Antonio Giordano et al. profile →
From Cell–ECM interactions to tissue engineering

2003 507 citations Francesco Rosso, Antonio Giordano et al. Journal of Cellular Physiology profile →
From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells

2007 485 citations Antonio Giordano et al. Journal of Cellular Physiology profile →
Role of p53 in the Regulation of Cellular Senescence

2020 408 citations Antonio Giordano et al. profile →
p53 signaling in cancer progression and therapy

2021 339 citations Andrea Morrione, Antonio Giordano et al. profile →
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications

2023 270 citations Alfredo Caturano, Vincenzo Russo et al. profile →
Virtual Reality as a Distraction Intervention to Relieve Pain and Distress During Medical Procedures

2018 254 citations Paola Indovina, Andrea Chirico et al. profile →

Peers

Antonio Giordano

ONCOL

PRM

GENET

Gerry Melino Italy

Lin Zhang China

Robert J. Coffey United States

Takashi Takahashi Japan

Doménico Ribatti Italy

Qing‐Yu He China

Yuquan Wei China

Michael Dean United States

Yasunori Okada Japan

Jian Zhang China

Gerry Melino Italy

Antonio Giordano

22.1k ×1.1

11.0k ×0.8

ONCOL

7.1k ×1.1

4.1k ×1.0

PRM

2.4k ×0.8

GENET

Citations per year, relative to Antonio Giordano Antonio Giordano (= 1×) peers Gerry Melino

Countries citing papers authored by Antonio Giordano

Since Specialization

Citations

This map shows the geographic impact of Antonio Giordano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Giordano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Giordano more than expected).

Fields of papers citing papers by Antonio Giordano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Giordano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Giordano. The network helps show where Antonio Giordano may publish in the future.

Co-authorship network of co-authors of Antonio Giordano

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Giordano. A scholar is included among the top collaborators of Antonio Giordano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Giordano. Antonio Giordano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Singh, Sima, Antonella Miglione, Canio Martinelli, et al.. (2025). Electrochemical (bio)sensors for cancer therapy monitoring. Electrochimica Acta. 537. 146929–146929. 2 indexed citations

Caturano, Alfredo, Enes Erul, Vincenzo Russo, et al.. (2025). Metabolic dysfunction‐associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad. European Journal of Clinical Investigation. 56(1). e70132–e70132.

Caturano, Alfredo, Biagio Liccardo, Marco Alfonso Perrone, et al.. (2025). Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence. Journal of Clinical Medicine. 14(5). 1652–1652. 5 indexed citations

Costa, Aurora, et al.. (2024). Capsaicin Exerts Antitumor Activity in Mesothelioma Cells. Nutrients. 16(21). 3758–3758. 4 indexed citations

Fiore, Riccardo Di, Rosa Drago‐Ferrante, Yashwanth Subbannayya, et al.. (2023). The Role of FBXW7 in Gynecologic Malignancies. Cells. 12(10). 1415–1415. 10 indexed citations

Palchetti, Sara, Mina Massaro‐Giordano, Marina Di Domenico, et al.. (2021). Artificial Protein Coronas Enable Controlled Interaction with Corneal Epithelial Cells: New Opportunities for Ocular Drug Delivery. Pharmaceutics. 13(6). 867–867. 12 indexed citations

Iannuzzi, Carmelina Antonella, et al.. (2021). RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways. Cancers. 13(19). 5025–5025. 9 indexed citations

Indovina, Paola, Iris Maria Forte, Francesca Pentimalli, & Antonio Giordano. (2020). Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade. Cancers. 12(7). 1866–1866. 7 indexed citations

Damiano, Sara, Luigi Navas, Serena Montagnaro, et al.. (2018). Effects of δ‐tocotrienol on ochratoxin A—induced nephrotoxicity in rats. Journal of Cellular Physiology. 233(11). 8731–8739. 19 indexed citations

10.

Astarita, Carlo, Mina Massaro‐Giordano, Silvia Boffo, et al.. (2018). Effect of sex steroid hormone fluctuations in the pathophysiology of male‐retinal pigment epithelial cells. Journal of Cellular Physiology. 233(9). 6965–6974. 2 indexed citations

11.

Morales, Fátima, et al.. (2017). CDK9: A key player in cancer and other diseases. Journal of Cellular Biochemistry. 119(2). 1273–1284. 97 indexed citations

12.

Cimini, Annamaria, Michele d’Angelo, Elisabetta Benedetti, et al.. (2016). Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs. Journal of Cellular Physiology. 232(2). 312–322. 21 indexed citations

13.

Faa, Gavino, Vassilios Fanos, & Antonio Giordano. (2016). Past and future of stem cells: from Prometheus to regenerative medicine. SHILAP Revista de lepidopterología. 5(2). 1 indexed citations

14.

Moss, Timothy, Andrea Chirico, Luca Mallia, et al.. (2016). Psychosocial Outcomes of Quadrantectomy Versus Mastectomy in a Southern Italian Sample: Development and Needs of the Italian Derriford Appearance Scale 24.. PubMed. 36(4). 1519–26. 1 indexed citations

15.

Fiore, Riccardo Di, Rosa Drago‐Ferrante, Francesca Pentimalli, et al.. (2014). MicroRNA-29b-1 impairs in vitro cell proliferation, self-renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells. International Journal of Oncology. 45(5). 2013–2023. 55 indexed citations

16.

Giordano, Antonio, Brian L. Egleston, David Hajage, et al.. (2013). Establishment and Validation of Circulating Tumor Cell–Based Prognostic Nomograms in First-Line Metastatic Breast Cancer Patients. Clinical Cancer Research. 19(6). 1596–1602. 36 indexed citations

17.

Leone, Emanuela, Eugenio Morelli, Maria Teresa Di Martino, et al.. (2013). Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth. Clinical Cancer Research. 19(8). 2096–2106. 184 indexed citations

18.

Malafoglia, Valentina, Bruce P. Bryant, William Raffaeli, Antonio Giordano, & Gianfranco Bellipanni. (2013). The zebrafish as a model for nociception studies. Journal of Cellular Physiology. 228(10). 1956–1966. 52 indexed citations

19.

Rosso, Francesco, G. Marino, Antonio Giordano, et al.. (2006). Rosso F, Marino G, Giordano A, Barbarisi M, Parmeggiani D, Barbarisi A. Smart materials as scaffolds for tissue engineering, Journal of Cellular Physiology (2005) 203(3) 465–470. Journal of Cellular Physiology. 209(3). 1054–1054. 1 indexed citations

20.

Giordano, Antonio, Youcef M. Rustum, & Charles E. Wenner. (1998). Cell cycle: Molecular targets for diagnosis and therapy: Tumor suppressor genes and cell cycle progression in cancer. Journal of Cellular Biochemistry. 70(1). 1–7. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact